76 related articles for article (PubMed ID: 9211637)
1. How viruses hide from T cells.
McMichael A
Trends Microbiol; 1997 Jun; 5(6):211-2; discussion 212-3. PubMed ID: 9211637
[No Abstract] [Full Text] [Related]
2. Viral interference with antigen presentation.
Yewdell JW; Hill AB
Nat Immunol; 2002 Nov; 3(11):1019-25. PubMed ID: 12407410
[TBL] [Abstract][Full Text] [Related]
3. [Viral strategies of interference with MHC functions].
Ishido S; Goto E; Sato Y; Hotta H
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2145-51. PubMed ID: 12518428
[No Abstract] [Full Text] [Related]
4. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
5. Subversion of the MHC class I antigen-presentation pathway by adenoviruses and herpes simplex viruses.
Burgert HG
Trends Microbiol; 1996 Mar; 4(3):107-12. PubMed ID: 8868089
[No Abstract] [Full Text] [Related]
6. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
Sigal LJ; Crotty S; Andino R; Rock KL
Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
[TBL] [Abstract][Full Text] [Related]
7. Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.
Wiertz EJ; Devlin R; Collins HL; Ressing ME
J Virol; 2007 May; 81(9):4389-96. PubMed ID: 17079308
[No Abstract] [Full Text] [Related]
8. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.
Lybarger L; Wang X; Harris M; Hansen TH
Curr Opin Immunol; 2005 Feb; 17(1):71-8. PubMed ID: 15653314
[TBL] [Abstract][Full Text] [Related]
9. Immunodominance of a single CTL epitope in a primate species with limited MHC class I polymorphism.
Evans DT; Piekarczyk MS; Allen TM; Boyson JE; Yeager M; Hughes AL; Gotch FM; Hinshaw VS; Watkins DI
J Immunol; 1997 Aug; 159(3):1374-82. PubMed ID: 9233634
[TBL] [Abstract][Full Text] [Related]
10. On cross-priming of MHC class I-specific CTL: rule or exception?
Zinkernagel RM
Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
[No Abstract] [Full Text] [Related]
11. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
[TBL] [Abstract][Full Text] [Related]
12. Immunology. Accessory to murder.
Schumacher TN
Nature; 1999 Mar; 398(6722):26-7. PubMed ID: 10078525
[No Abstract] [Full Text] [Related]
13. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
[TBL] [Abstract][Full Text] [Related]
14. Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense.
Cerundolo V; de la Salle H
Semin Immunol; 2006 Dec; 18(6):330-6. PubMed ID: 16973375
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MHC class I antigen presentation by viral proteins.
Früh K; Ahn K; Peterson PA
J Mol Med (Berl); 1997 Jan; 75(1):18-27. PubMed ID: 9020380
[TBL] [Abstract][Full Text] [Related]
16. Viral modulation of NK cell immunity.
Lodoen MB; Lanier LL
Nat Rev Microbiol; 2005 Jan; 3(1):59-69. PubMed ID: 15608700
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation. Chewing the fat.
Parham P
Nature; 1994 Dec; 372(6507):615-6. PubMed ID: 7527497
[No Abstract] [Full Text] [Related]
18. Viral interference with MHC class I antigen presentation pathway: the battle continues.
Ambagala AP; Solheim JC; Srikumaran S
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
[TBL] [Abstract][Full Text] [Related]
19. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
[TBL] [Abstract][Full Text] [Related]
20. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
Hetttihewa LM
Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
